Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Health & Science Social issues Medicaid
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Breaking News: Europe Pharmaceuticals Biotechnology
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Health care industry Pfizer Inc Social issues
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals World Economy
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Novo Nordisk A/S IQVIA Holdings Inc Illumina Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Pfizer Inc Bristol/Myers Squibb Co Health care industry
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Health & Science Business Health care industry
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Business Health & Science Labor economy
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Health & Science Social issues Business
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags Amerisourcebergen Corp Business stocks
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Novo Nordisk A/S 23andMe Holding Co/ Breaking News: Technology
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Health care policy US: News LILLY DRN
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Daily Open Markets Market Outlook
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Health & Science Business Science
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Biotech and Pharmaceuticals Breaking News: Europe Novo Nordisk A/S
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Health care industry Pharmaceuticals Pfizer Inc
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Novo Nordisk A/S Prices Europe Markets
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Health care industry Social issues Health & Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health care industry Roche Holding AG Social issues
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Health care industry Technology Pharmaceuticals
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags LILLY DRN Healthy Returns GE HealthCare Technologies Inc
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Biotech and Pharmaceuticals Weight management Novo Nordisk A/S
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Microstrategy Inc Breaking News: Markets Wall Street
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Weight management Biotech and Pharmaceuticals Science
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Novo Nordisk A/S Best Buy Co Inc 5 Things to Know
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Business Health & Science Novo Nordisk A/S
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags LILLY DRN Biotechnology Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Healthy Returns Biotech and Pharmaceuticals Viking Therapeutics Inc
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Novo Nordisk A/S Science Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.